Himalaya Nutravedics India Ltd (BSE: 544943) is a Hyderabad, Telangana-based company in the Ayurvedic and Alternative Medicines industry. With a market capitalisation of ₹151 Cr, it ranks #2,881 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 2 in Ayurvedic and Alternative Medicines. At ₹173.00 (as of 16 Nov 2026), the share price is 8.4% below its 52-week high of ₹188.95 and 57.3% above its 52-week low of ₹109.95.
| Current Price | ₹173.00 |
|---|---|
| Market Cap | ₹151 Cr |
| BSE Code | 544943 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Ayurvedic and Alternative Medicines |
| P/E Ratio | 14.3 |
| Return on Assets | 27.59% |
| 52-Week Range | ₹109.95 – ₹188.95 |
| Beta (1Y) | -7.23 |
| Headquarters | Hyderabad, Telangana |
| Website | www.himalayanutravedics.com |
Delivery averaged 71.1% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Himalaya Nutravedics India Limited manufactures, markets, and distributes Ayurvedic and nutraceutical formulations in India. It operates through own-brand business segment under which it offers product across three categories, such as Ayurvedic formulations, proprietary Ayurvedic formulations, and nutraceutical supplements. The company offers its products across multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, and medicated oils. It also offers third party contract manufacturing services for other ayurvedic and nutraceutical companies. The company was incorporated in 2022 and is based in Hyderabad, India.
1. Manufacturing of ALL Kinds of Ayurvedic and Nutraceuticals Formulations-NA 2. NA-NA 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Kerala Ayurveda Ltd | ₹183 Cr | n/m | -117.53% | — | -63.8% |
| Himalaya Nutravedics India Ltd | ₹151 Cr | 14.3 | — | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Himalaya Nutravedics India Ltd is trading at ₹173.00, with a market capitalisation of ₹151 Cr.
Himalaya Nutravedics India Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Ayurvedic and Alternative Medicines).
Himalaya Nutravedics India Ltd has a P/E of 14.3.
Himalaya Nutravedics India Ltd is listed on the BSE under the scrip code 544943.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.